Previous 10 | Next 10 |
Psychedelic Penny Stocks Continue Gaining Ground Among Mainstream Investors Like any “fringe industry,” there’s plenty of hype and speculation driving momentum behind penny stocks in certain industries. Those of you who’ve been in the markets for the last few...
Gainers: Sigma Labs (SGLB) +162%.Check-Cap (CHEK) +110%.Rubius Therapeutics (RUBY) +69%.Luokung Technology (LKCO) +43%.Shaw Communications (SJR) +38%.RumbleON (RMBL) +38%.Aeterna Zentaris (AEZS) +31%.Baosheng Media (BAOS) +30%.Intec Pharma (NTEC) +29%.GenMark Diagnostics (GNMK)...
Gainers: Check-Cap CHEK +138%, Rubius Therapeutics RUBY +81%, Intec Pharma NTEC +33%, GenMark Diagnostics GNMK +29%, Acer Therapeutics (ACER) +18%.Losers: Entera Bio (ENTX) -16%, NLS Pharmaceutics (NLSP) -15%, Seelos Therapeutic...
Torchlight Energy Resources (TRCH) -15% on business combination timingRubius Therapeutics (RUBY) -14% on initial data for RTX-240 in solid tumorsEntera Bio (ENTX) -13%.Nova LifeStyle (NVFY) -12%.NLS Pharmaceutics (NLSP) -12%.Eli Lilly and Company (LLY) -7% after ...
Gainers: NLS Pharmaceutics (NLSP) +87%.Entera Bio (ENTX) +72%.Seelos Therapeutics (SEEL) +69%.Ebang International (EBON) +43%.Perpetua Resources (PPTA) +27%.AMREP (AXR) +21%.22nd Century (XXII) +19%.Aemetis (AMTX) +18%.LendingClub (LC) +18%.MicroVision (MVIS) +17%.Losers: Marker The...
Shares of Seelos Therapeutics (NASDAQ: SEEL) were skyrocketing 35.2% higher as of 11:01 a.m. EST on Friday. The huge gain came after BTIG initiated coverage on the stock with a buy recommendation and a one-year price target nearly 4.7 times higher than Seelos' closing price on Thurs...
Analysts Are Bullish On These Penny Stocks Looking for penny stocks to buy right now? You’re not alone. These cheap stocks have taken center stage this year as traders’ appetites for risk have dramatically increased. Whether you’re looking for Reddit penny stocks ...
Seelos Therapeutics (SEEL) has added ~29.0% in the premarket after analysts at BTIG initiated the coverage of the stock with a street high price target of $14.00 per share indicating ~360.5% upside to the previous close.Giving the stock a buy rating, the analysts Robert "Bert" Hazle...
Penny Stocks For This Week’s Watch List We’re heading into the end of the week and, of course, there are still plenty of penny stocks to watch. Not only is this because traders are constantly on the hunt for volatility, but also for the fact that small-cap stocks are o...
SLS-002 alone warrants an upside of at least 3x times in the event of full FDA approval. Market participants are underestimating the clinical trial success probabilities of SLS-002. SLS-005 (Trehalose) has a low probability of clinical trial success for ALS & Sanfilippo Syndro...
News, Short Squeeze, Breakout and More Instantly...
Seelos Therapeutics Inc. Company Name:
SEEL Stock Symbol:
NYSE Market:
Seelos Therapeutics Inc. Website:
The U.S. Drug Enforcement Administration (DEA) is claiming that a federal law that affords severely ill individuals the right to try investigational medications doesn’t apply to drugs classified under the Controlled Substances Act. This is in response to a lawsuit filed by a doctor in ...
Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations PR Newswire - Richard Pascoe appointed Chairman of the Board of Directors to spearhead the ongoing busi...
A recently published review has determined that using psilocybin to manage mental-health conditions doesn’t heighten the risk of paranoia. This discovery comes at a time when public interest in the therapeutic potential of psychedelics is increasing. The review was carried out by resea...